Adaptive Biotechnologies Corp (ADPT) officer exercises 105,762 options and sells 105,762 shares
Rhea-AI Filing Summary
Adaptive Biotechnologies Corp Chief People Officer Francis Lo exercised employee stock options covering 105,762 common shares at exercise prices of $7.80, $8.46 and $12.14, and sold 105,762 shares of common stock at a weighted average price of $22.59 on July 15, 2026.
After these transactions, he directly held 230,713 common shares and indirectly held 2,500 shares through his spouse. All transactions were effected under a Rule 10b5-1 trading plan adopted on September 15, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 105,762 shares ($2,389,164)
Net Sell
8 txns
Insider
LO FRANCIS
Role
Chief People Officer
Sold
105,762 shs ($2.39M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 59,374 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 23,677 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 22,711 | $0.00 | -- |
| Exercise | Common Stock | 59,374 | $7.80 | $463K |
| Exercise | Common Stock | 23,677 | $12.14 | $287K |
| Exercise | Common Stock | 22,711 | $8.46 | $192K |
| Sale | Common Stock | 105,762 | $22.59 | $2.39M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 0 shares (Direct);
Common Stock — 290,087 shares (Direct);
Common Stock — 2,500 shares (Indirect, By You Jin Lee (spouse))
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.49 to $22.78, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. The option is fully vested and exercisable. The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Key Figures
Shares sold: 105,762 shares of Common Stock
Weighted average sale price: $22.59 per share
Options exercised (shares): 105,762 shares
+4 more
7 metrics
Shares sold
105,762 shares of Common Stock
Sale on July 15, 2026 at weighted average price
Weighted average sale price
$22.59 per share
Common Stock sale; individual prices $22.49–$22.78
Options exercised (shares)
105,762 shares
Total underlying shares from three Stock Option exercises
Option strike prices
$7.80, $8.46, $12.14 per share
Exercise prices for Stock Option (right to buy) awards
Direct holdings after transactions
230,713 shares
Common Stock directly owned by Francis Lo after July 15, 2026
Indirect holdings after transactions
2,500 shares
Common Stock held indirectly through spouse You Jin Lee
Rule 10b5-1 plan adoption date
September 15, 2025
Trading plan governing the reported option exercises and sale
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (right to buy), indirect ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"transactions were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported for this transaction is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) with underlying Common Stock"
indirect ownership financial
"ownership type marked indirect, nature of ownership: By You Jin Lee (spouse)"
exercise or conversion of derivative security financial
"transaction_code M described as Exercise or conversion of derivative security"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Adaptive Biotechnologies (ADPT) report for Francis Lo on July 15, 2026?
On July 15, 2026, Chief People Officer Francis Lo exercised options and sold company stock. He exercised options for 105,762 shares at strikes of $7.80, $8.46 and $12.14, and sold 105,762 common shares at a weighted average of $22.59.
At what prices were Francis Lo’s Adaptive Biotechnologies (ADPT) stock options exercised and shares sold?
Lo exercised options with strike prices of $7.80, $8.46 and $12.14 per share. He sold 105,762 common shares at a weighted average of $22.59, with individual sale prices ranging from $22.49 to $22.78.
What happened to Francis Lo’s stock options in Adaptive Biotechnologies (ADPT) on July 15, 2026?
On July 15, 2026, Lo exercised employee stock options for 105,762 shares of common stock. The exercised options had strikes of $7.80, $8.46 and $12.14, and some option positions were reduced to 0 or lowered balances after exercise.